These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8147581)

  • 1. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
    Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
    Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
    Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.
    Storey A; Oates D; Banks L; Crawford L; Crook T
    Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
    Lappalainen K; Urtti A; Söderling E; Jääskeläinen I; Syrjänen K; Syrjänen S
    Biochim Biophys Acta; 1994 Dec; 1196(2):201-8. PubMed ID: 7841184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells.
    Venturini F; Braspenning J; Homann M; Gissmann L; Sczakiel G
    Nucleic Acids Res; 1999 Apr; 27(7):1585-92. PubMed ID: 10075988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM; Ting RC
    Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.
    Niu XY; Peng ZL; Duan WQ; Wang H; Wang P
    Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
    Kanamaru T; Takagi T; Takakura Y; Hashida M
    J Drug Target; 1998; 5(4):235-46. PubMed ID: 9713974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6/E7 RNA.
    Clawson GA; Miranda GQ; Sivarajah A; Xin P; Pan W; Thiboutot D; Christensen ND
    Gene Ther; 2004 Sep; 11(17):1331-41. PubMed ID: 15229628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA.
    Kari I; Syrjänen S; Johansson B; Peri P; He B; Roizman B; Hukkanen V
    Virol J; 2007 Jun; 4():47. PubMed ID: 17547759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16.
    Wong YF; Chung TK; Cheung TH; Lam SK; Chang AM
    Med Oncol; 1994; 11(3-4):149-51. PubMed ID: 7633836
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stable suppression of transcription of human papillomavirus type 18 (HPV 18) E6 and E7 genes in transformed rat fibroblasts: use of an antisense oligonucleotide to the E7 gene].
    Komissarova EV; Pantin VI; Pavlova LS; Borovkova TV; Soĭfer MV; Shtutman MS; Zarytova VF; Ivanova EM; Sats NV; Grineva NI
    Dokl Akad Nauk; 1994 Sep; 338(3):404-7. PubMed ID: 7820079
    [No Abstract]   [Full Text] [Related]  

  • 20. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.